cost effectiveness analysis

29
ECONOMIC EVALUATION OF HEALTH INTERVENTIONS Abdur Razzaque Sarker MHE (Health Economics), MSS (Economics) Health Economics and Financing Research, icddrb and PhD Fellow in Strathclyde University, UK Email: [email protected]

Upload: abdur-razzaque-sarker

Post on 13-Jan-2017

187 views

Category:

Healthcare


0 download

TRANSCRIPT

Page 1: Cost effectiveness analysis

ECONOMIC EVALUATION OF HEALTH INTERVENTIONS

Abdur Razzaque SarkerMHE (Health Economics), MSS (Economics)

Health Economics and Financing Research, icddrband

PhD Fellow in Strathclyde University, UKEmail: [email protected]

Page 2: Cost effectiveness analysis

2

Topic

Cost Analysis (Cont..) Cost Minimization Analysis Cost Effectiveness Analysis (CEA) Cost utility Analysis ( CUA) CEA/CUA Exercise Group Work

Page 3: Cost effectiveness analysis

3

What is economic evaluation?

Economic evaluation is the comparative analysis of at least two health care interventions or alternatives in terms of both their costs and consequences.

Page 4: Cost effectiveness analysis

4

Cost‐Minimization Analysis

Cost‐Effectiveness Analysis

Cost‐Utility Analysis

Cost‐Benefit Analysis

Types of Economic Evaluations

Page 5: Cost effectiveness analysis

5

Cost‐Minimization Analysis

Compare the costs of two or more interventions with identical outcome and choose the least costly one.

Page 6: Cost effectiveness analysis

6

Alternative AInjury prevention by building a speed-breakerCost per injury prevented = 500 TakaNumber of injury prevented = 200

Alternative BInjury prevention by building a foot over-bridgeCost per injury prevented = 1200 TakaNumber of injury prevented = 200

The outcomes (number of injury prevented) are identical for alternatives ‘A’ and ‘B’. Alternative ‘A’ has lower cost of intervention. Using CMA, we can choose alternative ‘A’, i.e. building a speed-breaker

Cost minimization analysis (CMA)

Page 7: Cost effectiveness analysis

7

Cost-effectiveness analysis (CEA) Compare ‘cost per consequence’ of two or

more interventions, where the consequences are measured by “natural” units (life years gained, saved years of life)

Page 8: Cost effectiveness analysis

8

OutcomeYears of life savedHospital days preventedNumber of case preventedReduction in cholesterolBlood pressure reduction

Page 9: Cost effectiveness analysis

9

Cost-effectiveness analysis (CEA) Cost-effectiveness ratio (CER)

Incremental cost-effectiveness ratio (ICER)

Page 10: Cost effectiveness analysis

10

If effectiveness of alternative ‘A’ is higher and its costs is lower than those of alternative ‘B’.

Alternative ‘A’ is called dominant Alternative ‘B’ is called dominated

Law of Dominance & Law of Extended Dominance

Alternative Cost Saved years of Life

'A' 2,000 600 'B' 3,000 500

Dominance

Page 11: Cost effectiveness analysis

11

Extended dominanceIf we compare the interventions based on ICERs, we choose that programs which is ‘more effective, using law of extended dominance’.

One intervention (C) is said to be ‘extended dominant’ if its ICER is lower than the previous intervention(B). And the rolled out intervention is called ‘extended dominated’ (B).

Alternative Cost Effect C E C/E‘No' 0 0 0 0 0

'A' 200 4 200 4 50

'B' 300 5 100 1 100

'C' 380 6 80 1 80

Alternative Cost Effect C E C/E‘No' 0 0 0 0 0

'A' 200 4 200 4 50

'B' 300 5 100 1 100

'C' 380 6 80 1 80Exte

nded

dom

inat

ed

Exte

nded

dom

inan

t

Page 12: Cost effectiveness analysis

12

Cost Utility Analysis ( CUA)

Page 13: Cost effectiveness analysis

13

Cost-utility analysisCompare ‘cost per consequence’ of two or more interventions, where the consequences are measured by “utility” related to health (quality-adjusted life years, disability adjusted life years)

Page 14: Cost effectiveness analysis

14

Page 15: Cost effectiveness analysis

15

Cost-utility analysis

Unlike CEA, effects in CUA are measured in terms of utility

- Quality-adjusted life years (QALYs)- Disability-adjusted life years (DALYs)

Page 16: Cost effectiveness analysis

16

Example Program Cost per

patients (C) life year saved

Quality increase

QALYs gain (E)

No program 0 0 0 0E (Pneumonia) 500 20 0.93 18.6A (Polio) 100 10 0.92 9.2D(Diphtheria) 400 19 0.88 16.72C(Syphilis) 300 15 0.86 12.9B (TB) 200 14 0.93 13.02

Page 17: Cost effectiveness analysis

17

There are five different treatment (interventions) for producing saved years of life (S YoL). Our aim is to choose those interventions which survive the cost-effectiveness analysis and to rank them from highest to lowest cost-effectiveness.

Cost per patients and S YoL are presented below. We assume that each disease group has 200 patients to be treated.Intervention Cost per

patients (C) SYoL (E)

No 0 0E (Pneumonia)

500 20

A (Polio) 100 10D (Diphtheria )

400 19

C (Syphilis) 300 15B (TB) 200 14

Example of allocating resources using cost-effectiveness and cost-utility

analysis

Page 18: Cost effectiveness analysis

18

Steps of choosing cost-effective interventions1. Sort the interventions according to ‘cost per patient’ in

ascending order2. Find dominated interventions 3. Keep the survived interventions using the same sorting

procedure as in step 14. Calculate ICER between interventions5. Find the interventions which are ‘extended dominated’

and roll them out 6. Keep the survived interventions 7. Calculate the ICER of the survived interventions and roll

out the ‘extended dominated interventions’ and continue this process until all extended dominant interventions are rolled out

8. Now you find the interventions which have survived the cost-effectiveness analysis

Page 19: Cost effectiveness analysis

19

Step 1: Sort in ascending order using cost of treatmentIntervention Cost per patients (C) SYoL (E)No 0 0A (Polio) 100 10B (TB) 200 14C(syphilis) 300 15D(Diptheria) 400 19E (Pneumonia) 500 20

Intervention Cost per patients (C)

SYoL (E)

No 0 0E (Pneumonia) 500 20A (Polio) 100 10D (Diphtheria ) 400 19C (Syphilis) 300 15B (TB) 200 14

Page 20: Cost effectiveness analysis

20

Step 2: Find Dominated interventions

There is no dominated intervention

Intervention Cost per patients (C) SYoL (E) No 0 0A (Polio) 100 10B (TB) 200 14C(Syphilis) 300 15D(Diptheria) 400 19E (Pneumonia) 500 20

If effectiveness of alternative ‘A’ is higher and its costs is lower than those of alternative ‘B’. Alternative ‘B’ is called dominated

Page 21: Cost effectiveness analysis

21

Intervention Cost per patients (C) S YoL (E)No 0 0A (Polio) 100 10B (TB) 200 14C(syphilis) 300 15D(Diptheria) 400 19E (Pneumonia) 500 20

Step 3: Keep the survived interventions using step 1All interventions are kept

Page 22: Cost effectiveness analysis

22

Step 4: Calculate ICER between interventions

Intervention

Cost per patients (C) SYoL (E) ∆C ∆E ∆C/∆E

No 0 0 0 0 0

A (Polio) 100 10100 10 10

B (TB) 200 14100 4 25

C(syphilis) 300 15100 1 100

D(Diptheria) 400 19

100 4 25

E (Pnumonia) 500 20

100 1 100

Page 23: Cost effectiveness analysis

23

Step 5: Find ‘extended dominated’ interventions and roll them out

Intervention Cost per patients (C)

SYoL (E)∆C ∆E ∆C/∆E

No 0 0 0 0 0A (Polio) 100 10 100 10 10B (TB) 200 14 100 4 25C(syphilis) 300 15 100 1 100D(Diphtheria) 400 19 100 4 25E (Pneumonia) 500 20 100 1 100

One intervention (D) is said to be ‘extended dominant’ if its ICER is lower than the previous intervention(C). Here, alternative D is called the extended dominant alternative. And the rolled out intervention is called ‘extended dominated’. Here , C is extended dominated by D.

Page 24: Cost effectiveness analysis

24

Step 6: Keep the survived interventions

Intervention Cost per patients (C)

S YoL (E)

No 0 0A (Polio) 100 10B (TB) 200 14D(Diphtheria) 400 19E (Pneumonia) 500 20

Step 7: Recalculate ICER of survived interventions and roll out the ‘extended dominated interventions’

Intervention Cost per patients (C)

S YoL (E) ∆C ∆E ∆C/∆ENo 0 0 0 0 0A (Polio) 100 10 100 10 10B (TB) 200 14 100 4 25D(Diphtheria) 400 19 200 5 40E (Pneumonia) 500 20 100 1 100

Observation: No ‘extended dominated intervention’ is found.

Page 25: Cost effectiveness analysis

25

Step 8: Interventions which have survived the cost-effectiveness analysis

Intervention Cost per patients (C)

S YoL (E)

No 0 0A (Polio) 100 10B (TB) 200 14D(Diphtheria) 400 19E (Pneumonia)

500 20

Here, A is most cost effective alternative.

Page 26: Cost effectiveness analysis

26

Allocating budget among the interventionsConditions: Total budget = US$ 80,000Maximum 200 patients from each disease group can be treated

How to allocate?We start allocating the budget in the most cost-effective intervention (A) and gradually allocate in the next ones. Alternative Cost per

patientS YoL No of

patients treated

Total cost of treatment

Budget left

Total S YoL

A 100 10 200 20,000 60,000 2,000B 200 14 200 40,000 20,000 2,800D 400 19 50 20,000 0 950E 500 20        Total     450 80,000   5,750

Result:Using the total budget (US$ 80,000 a sum of 450 patients can be treated whichGives a total saved years of life (SYoL) of 5,750.

Page 27: Cost effectiveness analysis

27

Any other combination gives maximum outcome based on budget??? Alternative

Cost per patient

S YoL No of patients treated

Total cost of treatment

Budget left

Total SYol

B 200 14 200 40,000 40,000 2800D 400 19 100 40,000 0 1900A 100 10        E 500 20        

Total     300     4700

Alternative Cost per patient

S YoL No of patients treated

Total cost of treatment

Budget left

Total SYol

D 400 19 200 80,000 0 3800A 100 10        B 200 14        E 500 20        

Total     200     3800

Page 28: Cost effectiveness analysis

28

Exercise